AlloSure Lung Assessment and Metagenomics Outcomes Study

Active, not recruitingOBSERVATIONAL
Enrollment

550

Participants

Timeline

Start Date

October 29, 2021

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Lung Transplant InfectionLung Transplant; ComplicationsLung Transplant Failure and Rejection
Trial Locations (22)

10016

NYU Langone Health, New York

10027

Columbia University Medical Center, New York

10467

Montefiore Medical Center, The Bronx

19104

University of Pennsylvania, Philadelphia

19140

Temple University, Philadelphia

21201

University of Mayland, Baltimore

22042

Inova, Falls Church

32804

AdventHealth Orlando, Orlando

35233

University of Alabama (UAB), Birmingham

37232

Vanderbilt University Medical Center, Nashville

40202

University of Louisville Health, Louisville

43210

Ohio State University, Columbus

53792

University of Wisconsin Madison, Madison

60153

Loyola University Medical School, Maywood

63110

Washington University-Barnes Jewish Hospital, St Louis

77030

UT Health/ Memorial Hermann Hospital, Houston

80045

University of CO Anschutz Medical Campus, Aurora

85013

St. Joseph's Hospital & Medical Center, Phoenix

90048

Cedars Sinai Medical Center, Los Angeles

94143

University of California (UCSF) School of Medicine, San Francisco

02115

Brigham and Womens Hospital, Boston

M5G 2C4

Toronto General Hospital, Toronto

Sponsors

Lead Sponsor

All Listed Sponsors
lead

CareDx

INDUSTRY

NCT05050955 - AlloSure Lung Assessment and Metagenomics Outcomes Study | Biotech Hunter | Biotech Hunter